caelililly120325.jpg
Indiana University President Pamela Whitten and Eli Lilly Chair and CEO David Ricks sign an agreement during an event Dec. 3, 2025, at IU Indianapolis. Lilly agreed to give IU $40 million to expand clinical trials in Indiana.
Indiana University President Pamela Whitten and Eli Lilly Chair and CEO David Ricks sign an agreement during an event Dec. 3, 2025, at IU Indianapolis. Lilly agreed to give IU $40 million to expand clinical trials in Indiana. Courtesy Photo
Indiana University President Pamela Whitten and Eli Lilly Chair and CEO David Ricks sign an agreement during an event Dec. 3, 2025, at IU Indianapolis. Lilly agreed to give IU $40 million to expand clinical trials in Indiana.